One of the reasons the Sp is at this level is because the...

One of the reasons the Sp is at this level is because the Company is still a speculative stock and there is some significant de risking to happen before commercialisation.
I am always disappointed when an ann trumpets things like "...achieves Major Milestone..." then it turns out to just be an update!
The update itself, however, is worth reading in detail as it clearly paints the current position, remembering it is prepared from a Company point of view and is not a results based missive.
CDX is trying, along with many other (major) Companies to be first to market, however the ann also details what the Company believes are advantages that CDX have over their rivals including the SphygmorCor Technology and various partnerships.
These may well be fact or they can turn to dust, however at this stage CDX is still one of many "belief" stocks.
I found it interesting the mention of competitors (Apple, Samsung, Microsoft, Google, or Amazon) who have all " invested in dedicated healthcare teams internally looking to build a set of solutions, consumer applications and monitoring devices around large-scale population health disorders"
While CDX believes it has competitive advantages over these Companies, it is also true that large companies such as these are formidable!
Of course, if CDX were able to bring an approved technology to market these Companies would certainly have the firepower for a takeover and the decision would be does CDX wish to be a market leader or take the money and run. Either way I doubt if there would be many disappointed holders.
Getting necessary results and approvals is obviously not easy and at the moment the Company remains a small cap hopeful!
If CDX can achieve it's objectives and tie in the technology with an approved product obviously this SP will be considered a gift.
The market, however, needs to see much more de risking before the Company is re rated.
Obviously Mr Cooper expects to make money from this venture so his invested money (and desire for shares) can be considered a plus, however at the end of the day doesn't guarantee success. ​